July 15 (Reuters) - Longview Acquisition Corp II :
* HEARTFLOW, THE LEADER IN PRECISION HEART CARE, ANNOUNCES MERGER WITH LONGVIEW ACQUISITION CORP. II TO BECOME A PUBLICLY TRADED COMPANY
* LONGVIEW ACQUISITION CORP II - COMBINED PRO FORMA ENTERPRISE VALUE IS APPROXIMATELY $2.4 BILLION
* LONGVIEW ACQUISITION CORP II - TRANSACTION SUPPORTED BY EXISTING INSTITUTIONAL SHAREHOLDERS
* LONGVIEW ACQUISITION CORP II - DEAL WILL ALSO PROVIDE COMBINED COMPANY WITH AN ESTIMATED $400 MILLION IN CASH FOR GROWTH CAPITAL
* LONGVIEW ACQUISITION CORP II - DEAL EXPECTED TO DELIVER UP TO $599 MILLION OF GROSS PROCEEDS TO HEARTFLOW
* LONGVIEW ACQUISITION CORP II - ANY EXCESS CASH IN TRUST TO BE DISTRIBUTED BY CO TO SHAREHOLDERS THROUGH SPECIAL DIVIDEND OF UP TO $91 MILLION PRIOR TO CLOSING
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。